Triple
T10214642
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Ixifi |
E242410
|
entity |
| Predicate | hasActiveSubstance |
P69332
|
FINISHED |
| Object |
infliximab-qbtx
Infliximab-qbtx is a monoclonal antibody biosimilar to infliximab used to treat autoimmune inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
|
E850384
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69d381ae26c48190985abd0e25ee5d04 |
elicitation | completed |
| NER | batch_69d4d1f860048190bb20f7d3bf87f347 |
ner | completed |
| NED1 | batch_69d6a7f6730081908b941eaeb6c00993 |
ned_source_triple | completed |
| NED2 | batch_69d6d02015bc8190a7041a7d725c8a1b |
ned_description | completed |
| NEDg | batch_69d6ad94a6a881908d4c3b4408695d5b |
nedg | completed |
Created at: April 6, 2026, 11:04 a.m.